MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - NATCO PHARMA

Natco Pharma

BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01018 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 24, 17:00
435.65
1.05 (+0.24%)
VOLUME 1,240
AVERAGE VOLUME
5-Day 4,404
10-Day 4,494
30-Day 8,623
VOLUME SHOCKER
5-Day 4,404
10-Day 4,494
30-Day 8,623
Prev. Close
434.60
Open Price
403.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
435.65 (35)
Today’s Low/High 403.00 443.20
52 Wk Low/High 330.00 505.20
LIVE
NSE
May 24, 17:00
435.05
0.40 (+0.09%)
VOLUME 16,521
AVERAGE VOLUME
5-Day 40,860
10-Day 36,167
30-Day 34,249
VOLUME SHOCKER
5-Day 40,860
10-Day 36,167
30-Day 34,249
Prev. Close
434.65
Open Price
443.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 430.00 443.00
52 Wk Low/High 330.00 524.80
MARKET CAP (Rs Cr)
1,366.77
*P/E
16.89
*BOOK VALUE (Rs)
149.07
DIV (%)
30.00%
Market Lot
1
INDUSTRY P/E
27.54
*EPS (TTM)
25.80
*P/C
14.19
*PRICE/BOOK
2.92
DIV YIELD.(%)
0.69%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
88.37 new
DELIVERY AVERAGES
3-Day 71.68%
5-Day 68.96%
8-Day 59.24%
* Based on standalone numbers
Track Natco Pharma on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 30-May-2013 (Audited Results)
EXPAND ALL COLLAPSE ALL
Would you bet on Natco Pharma today?
Test your strategy with virtual money on Moneybhai
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 385.00 403.00  
High Price 395.40 443.20  
Low Price 384.50 403.00  
Last Price 389.40 435.65 11.88
Volume 51,111 1,240 -97.57
Simple Moving Averages
Days BSE NSE
30 437.00 436.99
50 436.13 436.27
150 434.94 435.16
200 417.54 417.69

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Natco Pharma

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Dec '12)
Quarterly
(Mar '12)
Yearly
Net Sales 150.31 467.63
Other Income 5.70 3.27
PBDIT 53.09 120.88
Net Profit 24.37 62.13

Annual Report

Download in PDF format 2012 |2011 |2010
Balance Sheet
(Mar '12)
(In Rs Cr)
Total Share Capital 31.15
Net Worth 467.47
Total Debt 215.74
Net Block 301.81
Investments 75.94
Net Current Assets 141.03
Total Assets 683.21
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 969.65 -3.67 1016.70 569.00 100,415.20
Dr Reddys Labs 2065.20 0.69 2150.90 1555.00 35,074.63
Lupin 769.80 2.79 810.80 519.00 34,459.10
Cipla 408.25 -1.63 435.00 305.00 32,779.26
GlaxoSmithKline 2267.65 -0.52 2522.00 2005.00 19,207.68
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Dec' 12Jun' 12Dec' 11Sep' 11
Promoter56.6457.0557.0163.11
FII7.737.725.936.36
DII9.6010.2811.838.86
Others26.0324.9525.2321.67
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
NATCO House, Road No.2,,Banjara Hills
City
Hyderabad
State
Andhra Pradesh
Pin Code
500033
Tel. No.
040-23547532
Fax No.
040-23548243
REGISTRARS
Name
Venture Capital & Corporate Investments Pvt. Ltd.
Address
No. 12-10-167, Bharat Nagar
City
Hyderabad - 500018
State
Andhra Pradesh
Tel. No.
040-23818475, 23818476, 23868023
Fax No.
040-23868024
MANAGEMENT
Name
Designation
V C Nannapaneni
Chairman & Managing Director
Rajeev Nannapaneni
Vice Chairman & CEO
P Bhaskara Narayana
Director & CFO
A K S Bhujanga Rao
Director
Nitin Jagannath Deshmukh
Additional Director
Message Board & Community
Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.